Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Genky DrugStores Co., Ltd. ( (JP:9267) ) has issued an announcement.
Genky DrugStores reported consolidated financial results for the first half of fiscal 2025, showing a 7.4% increase in net sales to 98,758 million yen. Despite the positive growth, the increase in operating income was modest at 4.8%, reflecting a potential challenge in cost management or competition. The company announced no revisions to its full-year forecast, maintaining a 9.3% growth prediction in net sales and a 10.9% rise in operating income, reinforcing its stable market position.
More about Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily operating in the retail sector, with a focus on drugstores. The company offers a range of health and beauty products, aiming at serving the Japanese market.
YTD Price Performance: -3.36%
Average Trading Volume: 52,247
Technical Sentiment Consensus Rating: Sell
Current Market Cap: Yen92.7B
For detailed information about 9267 stock, go to TipRanks’ Stock Analysis page.
